Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01EE05	TAFLUPRO	G	Tafluprost - 0.0015%	0.0015%	Solution	1,912,288 L.L
S01EE04	TRAVATAN	B	Travoprost - 40mcg/ml	0.004%	Drops solution	806,306 L.L
S01EE04	TRAVONORM	G	Travoprost - 0.004%	0.004%	Drops	564,414 L.L
S01EE01	API-LOPROST	G	Latanoprost - 0.005%	0.005%	Drops	447,500 L.L
S01EB02	MIOSTAT STERIL INTRAOCULAR	B	Carbachol - 0.01%	0.01%	Solution	8,117,591 L.L
D03AX06	BECAPLEX	BioTech	Becaplermin - 40mg	0.01%	Gel	38,029,953 L.L
G03CA03	MONTADIOL	G	Estradiol - 0.01%	0.01%	Cream	1,105,982 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/g	0.01g/g	Cream	344,024 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/ml	0.01g/ml	Solution	368,213 L.L
S01EE06	VYZULTA	B	Latanoprostene bunod - 0.024%	0.024%	Solution	1,948,572 L.L
D10AD01	TRETINOIN	G	Tretinoin - 0.025%	0.025%	Solution	564,414 L.L
J07AP03	TYPHIM VI	B	Salmonella typhi polysaccharides - 0.025mg/0.5ml	0.025mg/0.5ml	Injectable solution	1,118,077 L.L
S01BC04	EDOLFENE	B	Flurbiprofen sodium - 0.03%	0.03%	Drops solution	388,370 L.L
S01BC04	FLUROPTIC	G	Flurbiprofen sodium - 0.03% w/v	0.03% w/v	Drops solution	223,078 L.L
D07AC01	DIPROSONE	B	Betamethasone (dipropionate) - 0.5mg/g	0.05%	Cream	291,614 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Solution	260,705 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	155,886 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	108,851 L.L
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
D07AD01	CLOBEVAT	G	Clobetasol (propionate) - 0.05%	0.05%	Cream	302,045 L.L
D07AD01	DECLOBAN	G	Clobetasol (propionate) - 0.05%	0.05%	Cream	302,045 L.L
D07AD01	DERMASONE	G	Clobetasol (propionate) - 0.05%	0.05%	Cream	119,026 L.L
R01AD09	NASONEX	B	Mometasone furoate (monohydrate) - 50mcg/dose	0.05%	Spray, suspension	529,474 L.L
D07AD01	CLOBEVAT	G	Clobetasol (propionate) - 0.05%	0.05%	Ointment	302,045 L.L
R01AD09	AVOCOM	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
D07AD01	DECLOBAN	G	Clobetasol (propionate) - 0.05%	0.05%	Ointment	302,045 L.L
R01AD09	SINOCORT METERED DOSE	G	Mometasone furoate - 0.05%	0.05%	Spray, suspension	419,279 L.L
R01AD09	TABUNEX	G	Mometasone furoate - 0.05%	0.05%	Spray	419,279 L.L
D10AD01	A-RET	G	Tretinoin - 0.05%	0.05%	Cream	335,961 L.L
D10AD01	AVOTIN-A	G	Tretinoin - 0.05%	0.05%	Cream	440,780 L.L